Merck & Co (MRK)
64.41
+0.37 +0.58%
NYSE
May 23, 10:49
Delayed 2m
USD
View All Key Stats
MRK Key Stats
| Income Statement | |
| Revenue (TTM) | 39.93B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.56 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 4.345B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 68.04% |
| Profit Margin (Quarterly) | 16.44% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 2.89% |
| Price and Valuation | |
| Market Cap | 176.17B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.483 |
| PE Ratio (TTM) | 41.29 |
| Price to Book Value | 4.422 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.7148 |
| Free Cash Flow (Quarterly) | -53.00M |
| Return on Equity (TTM) | 10.30% |
View All MRK News
MRK News
-
WireHeadlineTime (ET)
-
Yahoo05/23 09:57
-
Yahoo05/23 08:14
-
SA Breaking News05/23 07:20
-
MT Newswires05/23 07:11
-
Business Wire05/23 06:55
-
Yahoo05/23 06:05
-
Yahoo05/23 06:00
-
Yahoo05/23 05:01
-
Yahoo05/22 16:47
-
SA Breaking News05/22 12:46
View All Events
MRK Events
| Date | Type | Description |
|---|---|---|
| 05/23/2017 09:00 EDT | Misc | Merck & Co Inc Annual General Meeting in 2016 |
| 05/02/2017 08:00 EDT | Misc | Merck & Co Inc First Quarter Earnings Conference Call in 2017 |
| 05/02/2017 | Earnings | Merck & Co Inc First Quarter Earnings in 2017 Release |
| 03/22/2017 | Misc | Merck Animal Health Completes Acquisition of Vallée s.A. |
| 03/13/2017 | Dividends | Amount: 0.47, Declared Date: Mar 01 2017, Pay Date: Apr 07 2017 |
| 02/02/2017 08:00 EDT | Misc | Merck & Co Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/02/2017 | Earnings | Merck & Co Inc Fourth Quarter Earnings in 2016 Release |
| 12/13/2016 | Dividends | Amount: 0.47, Declared Date: Nov 22 2016, Pay Date: Jan 09 2017 |
| 10/25/2016 08:00 EST | Misc | Merck & Co Inc Third Quarter Earnings Conference Call in 2016 |
| 10/25/2016 | Earnings | Merck & Co Inc Third Quarter Earnings in 2016 Release |
MRK Fundamentals
Income Statement View Statement
MRK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MRK One Page Reports
- One Page Report Download
MRK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 64.41 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.merck.com
- Investor Relations URL: http://investors.merck.com/investors/default.aspx
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Next Earnings Release: N/A
- Last Earnings Release: May. 02, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Mar. 13, 2017
- Description: Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health.
MRK Comparables
EditMRK Excel Add-In Codes
- Name: =YCI("MRK","name")
- Description: =YCI("MRK","description")
- Sector: =YCI("MRK","sector")
- Industry: =YCI("MRK","industry")
- Est. Current Fiscal Year End: =YCI("MRK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MRK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MRK Tweets Stocktwits
Advertisement